BRIEF published on 08/28/2024 at 11:44, 2 months 24 days ago BlackRock drops below 5% threshold of voting rights at Société Générale Voting Rights Stock Market BlackRock Threshold Crossing General Society
BRIEF published on 08/28/2024 at 10:03, 2 months 24 days ago BlackRock Crosses Threshold at Societe Generale Voting Rights BlackRock Threshold Crossing Transfer Of Shares General Society
BRIEF published on 08/28/2024 at 09:35, 2 months 24 days ago Threshold crossing and declaration of intent by SOCIETE GENERALE Société Générale Portfolio Management Capital Increase Threshold Crossing Declaration Of Intent
BRIEF published on 07/23/2024 at 10:59, 3 months 29 days ago Crossing of threshold by BlackRock at Société Générale Voting Rights Société Générale Asset Management BlackRock Crossing
BRIEF published on 07/22/2024 at 09:58, 3 months 30 days ago Crossing of threshold by BlackRock in SOCIETE GENERALE Voting Rights Société Générale Actions BlackRock Crossing Threshold
BRIEF published on 07/22/2024 at 09:48, 3 months 30 days ago BlackRock falls below the threshold of 5% of Société Générale’s voting rights Voting Rights Société Générale Actions BlackRock Crossing Threshold
BRIEF published on 07/19/2024 at 17:55, 4 months 1 day ago Société Générale: Half-yearly review of the liquidity contract Liquidity Contract Société Générale Half-yearly Report Securities Transactions Management Rothschild Martin Maurel
PRESS RELEASE published on 07/19/2024 at 17:50, 4 months 2 days ago Societe Generale: Half-Year statement on the Liquidity agreement SOCIETE GENERALE's half-year statement on liquidity agreement, including executed transactions and exchanged volumes. Liquidity contract temporarily suspended from 27 May 2024 to 25 June 2024 Société Générale Liquidity Agreement Executed Transactions Exchanged Volume Suspended
BRIEF published on 07/08/2024 at 18:01, 4 months 12 days ago Societe Generale: Shares & Voting Rights as of 30 June 2024 Voting Rights Société Générale Shares Financial Regulations
PRESS RELEASE published on 07/08/2024 at 17:56, 4 months 12 days ago Societe Generale: shares & voting rights as of 30 June 2024 SOCIETE GENERALE reports 802,979,942 shares composing current capital and 880,552,418 total voting rights as of 30 June 2024. The top tier European Bank highlights its ESG offerings and commitment to sustainability Voting Rights Société Générale Shares Sustainability ESG
Published on 11/21/2024 at 17:35, 18 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 23 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 23 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 52 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 53 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 15:41, 2 hours 11 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 31 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 55 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 33 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
